A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cell

• Publication date

  2009-04-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cell.2009.01.039PMID 19345189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.

  2009cited by this paper
• An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations.

  2007cited by this paper
• p63 and p73 in human cancer: defining the network

  2007influential reference
• Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation.

  2007cited by this paper
• Integration of TGF-ß and Ras/MAPK Signaling Through p53 Phosphorylation

  2007influential reference
• Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

  2006cited by this paper
• Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

  2006cited by this paper
• Concordance among gene-expression-based predictors for breast cancer.

  2006cited by this paper
• Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.

  2005cited by this paper
• Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

  2005cited by this paper
• Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.

  2004cited by this paper
• Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

  2004cited by this paper
• Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis

  2003cited by this paper
• Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.

  2003cited by this paper
• Metastasis is driven by sequential elevation of H-ras and Smad2 levels

  2002cited by this paper
• Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities*

  2002cited by this paper
• International Union Against Cancer

  2002cited by this paper
• A progression puzzle.

  2002cited by this paper
• TGF-β signaling in tumor suppression and cancer progression

  2001influential reference
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Assessing TP53 status in human tumours to evaluate clinical outcome

  2001cited by this paper
• A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core Domain

  2001cited by this paper
• TGF-beta signaling in tumor suppression and cancer progression.

  2001cited by this paper
• TGFb1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice

  1996cited by this paper

• HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects

  2025cites this paper
• Non-small cell lung cancer map and analysis: exploring interconnected oncogenic signal integrators

  2025cites this paper
• Molecular targets and therapies associated with poor prognosis of triple-negative breast cancer (Review)

  2025cites this paper
• Versatile roles of disordered transcription factor effector domains in transcriptional regulation

  2025cites this paper
• Unravelling the p53 misfolding by chaperones in cancer.

  2025cites this paper
• Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence

  2025cites this paper
• Mutant p53 regulates reversible subtype plasticity in pancreatic cancer

  2025cites this paper
• Interaction between Estrogen Receptors and p53: A Broader Role for Tamoxifen?

  2025cites this paper
• Cyclin G regulates hemocyte proliferation and antimicrobial peptide expression in the Chinese mitten crab (Eriocheir sinensis).

  2025cites this paper
• Transforming Growth Factor‐β Pathway: Biological Functions and Therapeutic Targets

  2025cites this paper
• Integrin factor (FAM27E3), as a metastatic marker of papillary thyroid carcinoma, through the p53 signaling pathway promoting lymph node metastasis

  2025cites this paper
• Mutant p53 regulates a distinct gene set by a mode of genome occupancy that is shared with wild type

  2025cites this paper
• Synthesis and Preclinical Development of a Novel 68Ga/89Zr-Labelled ανβ6-Integrin Targeting Trimer

  2025cites this paper
• Mutant p53: evolving perspectives

  2025cites this paper
• Human iPSC-based breast cancer model identifies S100P-dependent cancer stemness induced by BRCA1 mutation

  2025cites this paper
• PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression

  2025cites this paper
• Antimicrobial and Anticancer Activities of Lactiplantibacillus plantarum Probio87 Isolated from Human Breast Milk

  2025cites this paper
• Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer.

  2025cites this paper
• The Role of p53 as the Guardian of the Genome and the Consequences of its Mutation in Cancer Development: A Review

  2025cites this paper
• Targeting DNA Damage Response-Mediated Resistance in Non-Small Cell Lung Cancer: From Mechanistic Insights to Drug Development

  2025cites this paper
• Deciphering the significance of p53 mutant proteins.

  2024cites this paper
• Assessment and process optimization of high throughput biofabrication of immunocompetent breast cancer model for drug screening applications

  2024cites this paper
• p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications

  2024cites this paper
• Comprehensive molecular interaction map of TGFβ induced epithelial to mesenchymal transition in breast cancer

  2024cites this paper
• Potential Efficacy of 68Ga-Trivehexin PET/CT and Immunohistochemical Validation of αvβ6 Integrin Expression in Patients With Head and Neck Squamous Cell Carcinoma and Pancreatic Ductal Adenocarcinoma

  2024cites this paper
• The tumor-associated fibrotic reactions in microenvironment aggravate glioma chemoresistance

  2024cites this paper
• Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo

  2024cites this paper
• Fully-automated production of [68Ga]Ga-Trivehexin for clinical application and its biodistribution in healthy volunteers

  2024cites this paper
• Activating transcription factor 3 mediates apoptosis and cell cycle arrest in TP53-mutated anaplastic thyroid cancer cells

  2024cites this paper
• Regulatory crosstalk between TGF-β signaling and miRNAs: a head and neck cancer perspective

  2024cites this paper
• Natural Products for Combating Multidrug Resistance in Cancer.

  2024cites this paper
• Actin-Dependent Mechanism of Tumor Progression Induced by a Dysfunction of p53 Tumor Suppressor

  2024cites this paper
• Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α

  2024cites this paper
• Mutant p53 Exploits Enhancers to Elevate Immunosuppressive Chemokine Expression and Impair Immune Checkpoint Inhibitors in Pancreatic Cancer

  2024cites this paper
• Complex and variable regulation of ΔNp63 and TAp63 by TGFβ has implications for the dynamics of squamous cell epithelial to mesenchymal transition

  2024cites this paper
• p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator

  2024cites this paper
• Mutant p53-Mediated Tumor Secretome: Bridging Tumor Cells and Stromal Cells

  2024cites this paper
• The Molecular Landscape of Glioblastoma: Implications for Diagnosis and Therapy

  2024cites this paper
• Targeting mutant p53: a key player in breast cancer pathogenesis and beyond

  2024cites this paper
• Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

  2024cites this paper
• BHLHE41, a transcriptional repressor involved in physiological processes and tumor development

  2024cites this paper
• TP53 Mutations in Esophageal Squamous Cell Carcinoma.

  2023cites this paper
• SCFβTrCP-mediated degradation of SHARP1 in triple-negative breast cancer

  2023cites this paper
• Denticleless E3 ubiquitin protein ligase (DTL) maintains the proliferation and differentiation of epidermis and hair follicles during skin development

  2023cites this paper
• p63: a crucial player in epithelial stemness regulation

  2023cites this paper
• Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants.

  2023cites this paper
• Fyn-Mediated Paxillin Tyrosine 31 Phosphorylation Regulates Migration and Invasion of Breast Cancer Cells

  2023cites this paper
• Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants

  2023cites this paper
• microRNA-205 represses breast cancer metastasis by perturbing the rab coupling protein [RCP]-mediated integrin β1 recycling on the membrane

  2023cites this paper
• The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer

  2023cites this paper
• Mutual regulation of TGFβ-induced oncogenic EMT, cell cycle progression and the DDR.

  2023cites this paper
• The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma

  2023cites this paper
• Triple-negative breast tumors are dependent on mutant p53 for growth and survival

  2023cites this paper
• The role of p53 in anti-tumor immunity and response to immunotherapy

  2023cites this paper
• Targeting mutant-p53 for cancer treatment: Are we there yet?

  2023cites this paper
• Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis

  2023cites this paper
• Dysregulation of delta Np63 alpha in squamous cell carcinoma and its therapeutic targeting.

  2023cites this paper
• Anoikis resistance of small airway epithelium is involved in the progression of chronic obstructive pulmonary disease

  2023cites this paper
• PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma

  2023cites this paper
• Finding New Molecular Targets of Two Copper(II)-Hydrazone Complexes on Triple-Negative Breast Cancer Cells Using Mass-Spectrometry-Based Quantitative Proteomics

  2023cites this paper
• p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver Tumorigenesis

  2023cites this paper
• The High Presence of HCMV pp71 Proteins, Correlate with P63 Expression in Pancreatic Cancer Tumor Tissue

  2023cites this paper
• Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence

  2023cites this paper
• Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanism

  2023cites this paper
• Use of RNA-Seq and a Transgenic Mouse Model to Identify Genes Which May Contribute to Mutant p53-Driven Prostate Cancer Initiation

  2022cites this paper
• TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression

  2022cites this paper
• Differential gain-of-function activity of three p53 hotspot mutants in vivo.

  2022cites this paper
• The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway

  2022cites this paper
• Crizotinib Nanomicelles Synergize with Chemotherapy through Inducing Proteasomal Degradation of Mutp53 Proteins.

  2022cites this paper
• Presence of Concurrent TP53 Mutations Is Necessary to Predict Poor Outcomes within the SMAD4 Mutated Subgroup of Metastatic Colorectal Cancer

  2022cites this paper
• The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer

  2022cites this paper
• ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis

  2022cites this paper
• Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition

  2022cites this paper
• Oncogenic gain of function due to p53 amyloids by aberrant alteration of cell cycle and proliferation.

  2022cites this paper
• Roles of TGF-β in cancer hallmarks and emerging onco-therapeutic design

  2022cites this paper
• TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma

  2022cites this paper
• Beyond Genetics: Metastasis as an Adaptive Response in Breast Cancer

  2022cites this paper
• Should mutant TP53 be targeted for cancer therapy?

  2022cites this paper
• TGF-β1 Promotes Autophagy and Inhibits Apoptosis in Breast Cancer by Targeting TP63

  2022cites this paper
• Distinct interactors define the p63 transcriptional signature in epithelial development or cancer

  2022cites this paper
• Epidemiology of Glioblastoma Multiforme–Literature Review

  2022cites this paper
• Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches

  2021influential citation
• The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer

  2021cites this paper
• Mutant p53 as a Regulator and Target of Autophagy

  2021cites this paper
• Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer.

  2021cites this paper
• Cytokine Gene Polymorphism and Cancer Risk: A Promising Tool for Individual Susceptibility and Prognostic Implications

  2021cites this paper
• Cancer Stemness: p53 at the Wheel

  2021cites this paper
• It’s Time to Shift the Paradigm: Translation and Clinical Application of Non-αvβ3 Integrin Targeting Radiopharmaceuticals

  2021cites this paper
• Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members

  2021cites this paper
• A novel role of PRL in regulating epithelial cell density by inducing apoptosis at confluence.

  2021cites this paper
• TGF-β Paradox and the Progression of Osteoblastoma versus Osteosarcoma.

  2021cites this paper
• There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography

  2021cites this paper
• Targeted core-shell nanoparticles for precise CTCF gene insert in treatment of metastatic breast cancer.

  2021cites this paper
• YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation

  2021cites this paper
• Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy

  2021cites this paper
• p53 signaling in cancer progression and therapy

  2021cites this paper
• METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246

  2021cites this paper
• Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor

  2021cites this paper
• The Function of the Mutant p53-R175H in Cancer

  2021cites this paper
• Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes

  2021cites this paper